Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2026-01-11 @ 9:23 AM
Study NCT ID:
NCT05385861
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-08-15
First Post:
2022-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
Sponsor:
National Health Research Institutes, Taiwan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-09
First Submit QC Date:
None
Study First Post Date:
2022-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-14
Last Update Post Date:
2025-08-15
Last Update Post Date Type:
ACTUAL